Debx Medical

Recognized for Advancing Global Wound Care Through Innovation and EfficacyAMSTERDAM, April 30, 2025 (GLOBE NEWSWIRE) -- DEBRICHEM, the flagship product of DEBx Medical has been awarded the IIWCG Achievement

Chronic wounds that fail to progress despite months of treatment pose a significant challenge in clinical practice. In this study, patients with particularly large wounds (average 57.4 cm²) that had been present for an average of 4.5 months-despite multip

There's no one-size-fits-all solution in wound care. It requires a combination of strategies with wound-bed preparation being the foundation of every successful approach. However, persistent challenges such as re-infection and antibiotic resistance often

Granulation is a crucial step in wound healing, where new tissue forms over a wound to facilitate healing. Faster granulation means quicker recovery times and improved patient outcomes. Reaching granulation in wounds like Diabetic Foot Ulcers (DFUs), Carb

Standard of Care refers to guidelines and general adopted practices that healthcare professionals follow to treat wounds effectively. As wound care has evolved, T.I.M.E and eventually T.I.M.E.R.S. framework has been integrated into the Standard of Care to

In this article, you will find: Importance of Debridement: Why removing biofilm and necrotic tissue is critical for wound recovery. Debridement Methods: Insights on traditional techniques (surgical, autolytic, enzymatic, etc.). A chemical debridement meth

A Synergistic Approach for Rapid Granulation in Leg and Foot Ulcers Complete granulation achieved in 13.2 days on average for ulcers that persisted for on average 13 months (3-48 months). This result comes from a study that combined DEBRICHEM, a chemical

This article is about a patient with a history of multiple surgeries, including a left leg amputation, who presented with signs of pre-sepsis and significant challenges in wound management. Despite undergoing various treatments such as NPWT, fish skin app

Key Results First: 75% increase in the probability of healing with DEBRICHEM plus standard of care (SC) compared to SC alone. 57% reduction in wound management costs, reducing 12-month treatment costs from £7195 per patient to £3128 with DEBRICHEM. Health

REDEFINE WOUND CARE STANDARDS WITH DEBRICHEM DEBx Medical's product is an innovative topical dehydrating agent designed to remove infection and biofilm in hard-to-heal wounds, with a single 60-second application. WHY DEBRICHEM A new, disruptive and highly